Alexander A. Santini, EVP and CCO at LEXICON PHARMACEUTICALS, INC. (LXRX), bought 745 shares at $9.78 ($7K) on 2018-05-23, disclosed to the SEC on 2018-05-25.
Open-market purchase of $7k LXRX by EVP and CCO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Clearly above the average filing.